{"content":"<li class=\"n-box-item date-title\" data-end=\"1530590399\" data-start=\"1530504000\" data-txt=\"Monday, December 23, 2019\">Monday, July  2, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3367650\" data-ts=\"1530568486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367650-report-feds-expand-data-probe-facebook-sharesminus-1_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Feds expand data probe into Facebook; shares -1.4%</a></h4><ul>   <li>A federal probe into Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) is expanding, <i>The Washington Post</i> reports, with <a href=\"https://www.washingtonpost.com/technology/2018/07/02/federal-investigators-broaden-focus-facebooks-role-sharing-data-with-cambridge-analytica-examining-statements-tech-giant/?utm_term=.e6d96f834afd\" target=\"_blank\">three agencies now</a> parsing the company's statements over data-leak dealings with Cambridge Analytica.</li>    <li>The FBI, SEC and Federal Trade Commission have joined the Justice Dept. in the investigation, the report says.</li><li>Emphasis has been on whether Facebook's public declarations about the scandal square with underlying facts, and whether Facebook has been complete and timely about what it's said.</li>    <li>Shares are <font color='red'>down 1.4%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367650\" data-linked=\"Report: Feds expand data probe into Facebook; shares -1.4%\" data-tweet=\"$FB - Report: Feds expand data probe into Facebook; shares -1.4% https://seekingalpha.com/news/3367650-report-feds-expand-data-probe-facebook-sharesminus-1_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3367650-report-feds-expand-data-probe-facebook-sharesminus-1_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367646\" data-ts=\"1530566792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAMP\" target=\"_blank\">RAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367646-after-hours-gainers-losers-7-2-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (7/2/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/GLDD' title='Great Lakes Dredge & Dock Corporation'>GLDD</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/GHDX' title='Genomic Health, Inc.'>GHDX</a> <font color='green'>+3%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-6.7%</font>. <a href='https://seekingalpha.com/symbol/HZN' title='Horizon Global Corp'>HZN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/PCMI' title='PCM, Inc.'>PCMI</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/DHCP' title='Ditech Holding Corporation'>OTC:DHCP</a> <font color='red'>-2.8%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='red'>-2.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367646\" data-linked=\"After Hours Gainers / Losers (7/2/2018)\" data-tweet=\"$RAMP $RAMP $MLHR - After Hours Gainers / Losers (7/2/2018) https://seekingalpha.com/news/3367646-after-hours-gainers-losers-7-2-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367646-after-hours-gainers-losers-7-2-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367639\" data-ts=\"1530565383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLDD\" target=\"_blank\">GLDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367639-great-lakes-dredge-dockplus-3_9-on-164m-in-awards\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Lakes Dredge &amp; Dock +3.9% on $164M in awards</a></h4><ul>   <li>Great Lakes Dredge &amp; Dock (NASDAQ:<a href='https://seekingalpha.com/symbol/GLDD' title='Great Lakes Dredge & Dock Corporation'>GLDD</a>) is <font color='green'>up 3.9%</font> after hours following its announcement of $164M in awarded contracts.</li>    <li>That includes four deals for coastal protection (in New York, South Carolina, North Carolina and Maryland) along with the Corpus Christi La Quinta Channel Widening Project in Texas and the Delaware River Deepening Variation Order.</li>    <li>The company expects the coastal protection projects to be executed between now and May 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367639\" data-linked=\"Great Lakes Dredge &amp; Dock +3.9% on $164M in awards\" data-tweet=\"$GLDD - Great Lakes Dredge &amp; Dock +3.9% on $164M in awards https://seekingalpha.com/news/3367639-great-lakes-dredge-dockplus-3_9-on-164m-in-awards?source=tweet\" data-url=\"https://seekingalpha.com/news/3367639-great-lakes-dredge-dockplus-3_9-on-164m-in-awards\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367634\" data-ts=\"1530564843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAMP\" target=\"_blank\">RAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367634-acxiom-sells-bulk-of-company-to-interpublic-for-2_3b-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acxiom sells bulk of company to Interpublic for $2.3B (updated)</a></h4><ul>   <li>Acxiom (NYSE:<a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a>) -- <a href=\"https://seekingalpha.com/news/3366927-acxiom-plus-3_5-percent-1_5b-bids-seen-data-unit\" target=\"_blank\">on the move</a> in recent days as reports about <a href=\"https://seekingalpha.com/news/3367498-acxiom-plus-11_5-percent-interpublic-reportedly-nears-2_2b-unit-deal\" target=\"_blank\">selling its data-marketing unit</a> heated up -- has a definitive all-cash deal to <a href=\"https://seekingalpha.com/pr/17207410-acxiom-enters-definitive-agreement-sell-acxiom-marketing-solutions-2_3-billion-interpublic\" target=\"_blank\">sell the unit for $2.3B</a> to Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>).</li>    <li>That's higher than even the latest report of $2.2B. The deal's expected to close by the end of the calendar year.</li>    <li>The Acxiom Marketing Solutions Business makes up most of Acxiom's business.</li>    <li>Acxiom expects to realize about $1.7B in net cash proceeds, which it will use to retire its entire $230M in debt; launch a $500M cash tender for common stock; increase its buyback authorization by up to $500M; and fund growth initiatives, strategic acquisition opportunities and cash needs.</li>    <li>It's also transferring the Acxiom brand to IPG, and plans to rename itself LiveRamp (after its faster-growing remaining business) and seek the ticker symbol RAMP.</li>    <li>Shares in Acxiom rose steadily throughout the day to finish at a <font color='green'>14.2%</font> gain.</li><li><strong>Updated 5:13 p.m.:</strong>&nbsp;Shares are <font color='green'>up another 17.2%</font>&nbsp;after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367634\" data-linked=\"Acxiom sells bulk of company to Interpublic for $2.3B (updated)\" data-tweet=\"$RAMP $RAMP $IPG - Acxiom sells bulk of company to Interpublic for $2.3B (updated) https://seekingalpha.com/news/3367634-acxiom-sells-bulk-of-company-to-interpublic-for-2_3b-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3367634-acxiom-sells-bulk-of-company-to-interpublic-for-2_3b-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367603\" data-ts=\"1530562074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLHR\" target=\"_blank\">MLHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367603-herman-miller-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herman Miller beats by $0.08, beats on revenue</a></h4><ul><li>Herman Miller (NASDAQ:<a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a>): Q4 EPS of $0.66 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $618M (+7.1% Y/Y) <font color='green'>beats by $16.9M</font>.</li><li>Shares <font color='green'>+6.82%</font>.</li><li><a href='https://seekingalpha.com/pr/17207343-herman-miller-reports-fourth-quarter-fiscal-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3367603\" data-linked=\"Herman Miller beats by $0.08, beats on revenue\" data-tweet=\"$MLHR - Herman Miller beats by $0.08, beats on revenue https://seekingalpha.com/news/3367603-herman-miller-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3367603-herman-miller-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367602\" data-ts=\"1530561897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLT\" target=\"_blank\">PLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367602-plantronicsplus-2_1-on-closing-polycom-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plantronics +2.1% on closing Polycom acquisition</a></h4><ul><li>        Plantronics (NYSE:<a href='https://seekingalpha.com/symbol/PLT' title='Plantronics Inc.'>PLT</a>) <a href=\"https://seekingalpha.com/pr/17207243-plantronics-completes-acquisition-polycom\" target=\"_blank\">completes</a> its acquisition of Polycom.</li><li>               The acquisition is immediately accretive to non-GAAP EPS. Plantronics believes it can achieve annual run-rate cost synergies of $75M within 12 months.&nbsp;</li><li>               Plantronics acquired Polycom at a $2B enterprise value with the total consideration consisting of $1.64B in cash and 6.352M Plantronics shares. &nbsp;&nbsp;</li><li>                  Plantronics closed today&nbsp;<font color='green'>up 2.1%</font>&nbsp;to $77.81.&nbsp;&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3367602\" data-linked=\"Plantronics +2.1% on closing Polycom acquisition\" data-tweet=\"$PLT - Plantronics +2.1% on closing Polycom acquisition https://seekingalpha.com/news/3367602-plantronicsplus-2_1-on-closing-polycom-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3367602-plantronicsplus-2_1-on-closing-polycom-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367595\" data-ts=\"1530561700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367595-m-potential-seen-for-e-l-f-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">M&amp;A potential seen for e.l.f. Beauty</a></h4><ul> <li>D.A. Davidson thinks e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>) could be taken out at a 40% premium due to the recent decline in share price.</li> <li>The M&amp;A potential on ELF underpins D.A. Davidson's Buy rating on the online cosmetics stock.</li> <li>Unilever (<a href='https://seekingalpha.com/symbol/UN' title='Unilever NV'>UN</a>, <a href='https://seekingalpha.com/symbol/UL' title='Unilever Plc'>UL</a>, Coty (NYSE:<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a>) and Revlon (NYSE:<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a>) are mentioned as potential acquirers of e.l.f. Beauty.</li> <li>Shares of ELF are down 28% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367595\" data-linked=\"M&amp;A potential seen for e.l.f. Beauty\" data-tweet=\"$ELF $ELF $UN - M&amp;A potential seen for e.l.f. Beauty https://seekingalpha.com/news/3367595-m-potential-seen-for-e-l-f-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3367595-m-potential-seen-for-e-l-f-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367592\" data-ts=\"1530560546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLNK\" target=\"_blank\">NLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367592-newlinks-indoximod-shows-positive-action-in-early-stage-study-in-aggressive-type-of-brain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NewLink&#39;s indoximod shows positive action in early-stage study in aggressive type of brain tumor; shares up 3%</a></h4><ul><li>NewLink Genetics (<a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='green'>+3.4%</font>) is up on below-average volume on its <a href=\"https://seekingalpha.com/pr/17206741-newlink-genetics-announces-positive-updated-phase-1-data-indoximod-plus-radio-immunotherapy\" target=\"_blank\">announcement </a>of updated data from a Phase 1 clinical trial assessing indoximod + front-line radiation + maintenance chemo in patients with newly diagnosed <a href=\"https://www.stjude.org/disease/diffuse-intrinsic-pontine-glioma.html\" target=\"_blank\">diffuse intrinsic pontine glioma</a> &#40;DIPG&#41;, a treatment-resistant and aggressive type of tumor that starts in the brain stem. The results were presented at the International Symposium of Pediatric Neuro-Oncology Annual Meeting in Denver, CO.</li><li>All 10 treated patients showed initial symptomatic improvement. Nine of the 10 remain on study, the longest being 8.5 months. Historically, median survival is only nine months.</li><li>On the safety front, an unspecified subset of patients experienced adverse events, including inflammation, which were actively managed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367592\" data-linked=\"NewLink&#39;s indoximod shows positive action in early-stage study in aggressive type of brain tumor; shares up 3%\" data-tweet=\"$NLNK - NewLink&#39;s indoximod shows positive action in early-stage study in aggressive type of brain tumor; shares up 3% https://seekingalpha.com/news/3367592-newlinks-indoximod-shows-positive-action-in-early-stage-study-in-aggressive-type-of-brain?source=tweet\" data-url=\"https://seekingalpha.com/news/3367592-newlinks-indoximod-shows-positive-action-in-early-stage-study-in-aggressive-type-of-brain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367588\" data-ts=\"1530559844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MARK\" target=\"_blank\">MARK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367588-remark-amends-financing-purchase-agreements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Remark amends financing, purchase agreements</a></h4><ul><li>        Remark Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a>) <a href=\"http://ir.remarkmedia.com/news-releases/news-release-details/remark-holdings-enters-agreements-drive-long-term-strategy\" target=\"_blank\">enters</a> into an amended financing agreement with its lenders extending the repayment of $11.5M until September 28.</li><li>               The company also entered into a common stock purchase agreement with Aspire Capital allowing Aspire to buy as much as $30M of Remark stock over a 30-month term.&nbsp;</li><li>               Remark plans to deploy several AI products and will update investors on that process during the Q2 earnings call. &nbsp;&nbsp;</li><li>               Remark shares are&nbsp;<font color='green'>up 1.3%</font>&nbsp;to $3.96.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3367588\" data-linked=\"Remark amends financing, purchase agreements\" data-tweet=\"$MARK - Remark amends financing, purchase agreements https://seekingalpha.com/news/3367588-remark-amends-financing-purchase-agreements?source=tweet\" data-url=\"https://seekingalpha.com/news/3367588-remark-amends-financing-purchase-agreements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367584\" data-ts=\"1530559206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXMP\" target=\"_blank\">AXMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367584-axm-pharma-agrees-to-reverse-merger-cameroon-cocoa-exporter-shares-up-118\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AXM Pharma agrees to reverse merger with Cameroon cocoa exporter; shares up 118%</a></h4><ul><li>Thinly traded nano cap AXM Pharma (<a href='https://seekingalpha.com/symbol/AXMP' title='AXM Pharma, Inc.'>OTC:AXMP</a> <font color='green'>+117.6%</font>) rockets on a healthy 18x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17207189-axm-pharma-announces-proposed-reverse-merger-cameroon-billionaire-businessman\" target=\"_blank\">announcement </a>that it has inked a binding letter agreement for a reverse takeover by privately held AS Industries Cameroon &#40;ASIC&#41;, a cocoa exporter.</li><li>ASIC chief Emmanuel Neossi has acquired 70% of AXMP and has been appointed Chairman, replacing Mandla Gwadiso who stepped down.</li><li>The combined company will do business as AS Industries Cameroon.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367584\" data-linked=\"AXM Pharma agrees to reverse merger with Cameroon cocoa exporter; shares up 118%\" data-tweet=\"$AXMP - AXM Pharma agrees to reverse merger with Cameroon cocoa exporter; shares up 118% https://seekingalpha.com/news/3367584-axm-pharma-agrees-to-reverse-merger-cameroon-cocoa-exporter-shares-up-118?source=tweet\" data-url=\"https://seekingalpha.com/news/3367584-axm-pharma-agrees-to-reverse-merger-cameroon-cocoa-exporter-shares-up-118\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367583\" data-ts=\"1530559106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367583-chevron-canadian-natural-lagged-ready-to-move-up-goldman-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron, Canadian Natural have lagged but ready to move up, Goldman says</a></h4><ul>     <li>Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-2%</font>) and Canadian Natural Resources (<a href='https://seekingalpha.com/symbol/CNQ' title='Canadian Natural Resources, Ltd.'>CNQ</a> <font color='red'>-1.6%</font>) have lagged the energy sector's recent rise, but Goldman Sachs analyst Neil Mehta thinks the stocks remain <a href=\"https://www.barrons.com/articles/two-energy-stocks-to-buy-chevron-canadian-natural-1530542971?mod=hp_RTA\" target=\"_blank\">worthy of his Buy rating</a>, reiterating respective $142 and $43 price targets.</li>     <li>CVX shares have been weighed down by skepticism about the company's ability to execute, its appetite for M&amp;A and its focus in the congested Permian Basin, but Mehta still likes the stock, and he thinks CVX may announce stock buybacks and production updates about the Wheatstone Train 2 LNG project in Australia that could provide a boost.</li>     <li>CNQ has underperformend after a lackluster Q1 and because of its exposure to weak Canadian commodity prices, Mehta says, but he remains bullish on the belief that CNQ will benefit from strong cash flow returns this year, which will shore up the balance sheet and allow it to return more cash to shareholders.</li>     <li>By contrast, Mehta reiterates a Sell rating and $42 price target on PBF&nbsp;Energy (<a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a> <font color='red'>-1.3%</font>), citing \"concerns around the free cash flow power of the company, limited capital returns relative to refining peers, and history of operational underperformance.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3367583\" data-linked=\"Chevron, Canadian Natural have lagged but ready to move up, Goldman says\" data-tweet=\"$CVX $CVX $CNQ - Chevron, Canadian Natural have lagged but ready to move up, Goldman says https://seekingalpha.com/news/3367583-chevron-canadian-natural-lagged-ready-to-move-up-goldman-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3367583-chevron-canadian-natural-lagged-ready-to-move-up-goldman-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367581\" data-ts=\"1530558411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBMP\" target=\"_blank\">OBMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367581-oncbiomune-on-go-mid-stage-study-of-therapeutic-prostate-cancer-vaccine-shares-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncBioMune on go with mid-stage study of therapeutic prostate cancer vaccine; shares up 15%</a></h4><ul><li>Nano cap OncBioMune Pharmaceuticals (<a href='https://seekingalpha.com/symbol/OBMP' title='OncBioMune Pharmaceuticals, Inc.'>OTCPK:OBMP</a> <font color='green'>+14.8%</font>) is up on below-average volume on the <a href=\"https://seekingalpha.com/pr/17207265-oncbiomune-signs-work-order-phase-2-clinical-trial-proscavax-early-stage-prostate-cancer\" target=\"_blank\">news </a>that it has engaged a CRO to manage a Phase 2 clinical trial assessing lead candidate ProscaVax for the first-line treatment of patients with localized prostate cancer, the first mid-stage study evaluating a prostate cancer vaccine in an active surveillance mode.</li><li>The 120-subject study should commence this quarter.</li><li>ProscaVax is a combination of prostate specific antigen &#40;PSA&#41; and the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF).</li></ul><div class=\"tiny-share-widget\" data-id=\"3367581\" data-linked=\"OncBioMune on go with mid-stage study of therapeutic prostate cancer vaccine; shares up 15%\" data-tweet=\"$OBMP - OncBioMune on go with mid-stage study of therapeutic prostate cancer vaccine; shares up 15% https://seekingalpha.com/news/3367581-oncbiomune-on-go-mid-stage-study-of-therapeutic-prostate-cancer-vaccine-shares-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3367581-oncbiomune-on-go-mid-stage-study-of-therapeutic-prostate-cancer-vaccine-shares-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367578\" data-ts=\"1530558025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAMP\" target=\"_blank\">RAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367578-technology-top-5-gainers-losers-of-3-00-pm-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (07/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AMRH' title='Ameri Holdings, Inc.'>AMRH</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SYNT' title='Syntel, Inc.'>SYNT</a> <font color='green'>+9%</font>. DVMT <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SPCB' title='SuperCom, Ltd.'>SPCB</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/APPN' title='Appian Corp.'>APPN</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367578\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (07/02/2018)\" data-tweet=\"$RAMP $RAMP $AMRH - Technology - Top 5 Gainers / Losers as of 3:00 PM (07/02/2018) https://seekingalpha.com/news/3367578-technology-top-5-gainers-losers-of-3-00-pm-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367578-technology-top-5-gainers-losers-of-3-00-pm-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367563\" data-ts=\"1530555705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367563-seadrill-announces-exit-from-chapter-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill announces exit from Chapter 11</a></h4><ul>     <li>Seadrill (<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-34.9%</font>) says it has <a href=\"https://globenewswire.com/news-release/2018/07/02/1532610/0/en/SDRL-Seadrill-Announces-Emergence-from-Chapter-11.html\" target=\"_blank\">emerged from Chapter 11</a> bankruptcy after successfully completing its reorganization plan.</li>     <li>SDRL says the plan equitizes ~$2.4B in unsecured bond obligations, $1B-plus in contingent newbuild obligations and substantial unliquidated guaranty obligations while extending near term debt maturities, providing the company with more than $1B in fresh capital.</li>     <li>The company will list its new common shares on the NYSE under the same SDRL ticker, but investors \"should take note of the anticipated cancellation of the existing shares and issuance of new common shares, and the two different CUSIP numbers signifying the existing shares and the new common shares.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367563\" data-linked=\"Seadrill announces exit from Chapter 11\" data-tweet=\"$SDRL - Seadrill announces exit from Chapter 11 https://seekingalpha.com/news/3367563-seadrill-announces-exit-from-chapter-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3367563-seadrill-announces-exit-from-chapter-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>151&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367555\" data-ts=\"1530554822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367555-tesla-victory-lap-ends-early\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla victory lap ends early</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) is <font color='red'>down 2.52%</font> after an initial vibrant rally this morning following the company's update on production, deliveries and reservations.</li> <li>Volume on Tesla is over 14.3M shares vs. a 50-day avergage volume of 8.05M shares with two full hours of trading still on the clock.</li> <li>Chiming in today on Tesla and the 5K Model 3 production run rate was CFRA analyst Efraim Levy. \"In the interim, we do not see this production rate as operationally or financially sustainable,\" warned Levy. \"However, over time, we expect the manufacturing rate to become sustainable and even rise. As usual, we expect the bulls and bears to largely reiterate their views after the latest development,\" he added.</li> <li>CFRA lowered Tesla to a Sell rating from Hold to conform to its 12-month price target of $300 on the EV automaker.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367437-tesla-updates-production-reservations\" target=\"_blank\">Tesla updates on production and reservations</a> (July 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367555\" data-linked=\"Tesla victory lap ends early\" data-tweet=\"$TSLA - Tesla victory lap ends early https://seekingalpha.com/news/3367555-tesla-victory-lap-ends-early?source=tweet\" data-url=\"https://seekingalpha.com/news/3367555-tesla-victory-lap-ends-early\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>227&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367552\" data-ts=\"1530554444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367552-energy-materials-top-5-gainers-losers-of-2-00-pm-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+144%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc'>UUUU</a> <font color='green'>+11%</font>.</li><li><b>L</b><b>osers:</b> <a href='https://seekingalpha.com/symbol/CLB' title='Core Laboratories'>CLB</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FRAC' title='Keane Group'>FRAC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367552\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/02/2018)\" data-tweet=\"$GBR $GBR $SAEX - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/02/2018) https://seekingalpha.com/news/3367552-energy-materials-top-5-gainers-losers-of-2-00-pm-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367552-energy-materials-top-5-gainers-losers-of-2-00-pm-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367549\" data-ts=\"1530552155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRTS\" target=\"_blank\">RRTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367549-roadrunner-transportation-soars-after-business-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roadrunner Transportation soars after business update</a></h4><ul> <li>Roadrunner Transportation Systems (NYSE:<a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a>) <font color='green'>jumps 31.6%</font> after the company plays catch-up with its financial reporting and issues a positive assessment on current trends.</li> <li>\"Our recovery efforts are well timed, with an overall positive freight market. We know that improved short-term results while at times be bumpy and inconsistent, but looking at the bigger longer term picture, we are committed to improving each of our segments and our consolidated bottom-line results,\" noted Roadrunner CEO Curtis Stoelting on today's earnings call (<a href=\"https://seekingalpha.com/article/4185097-roadrunner-transportation-systems-inc-rrts-ceo-curtis-stoelting-q1-2018-results-earnings-call\" target=\"_blank\">transcript)</a>.</li><li>RRTS is still down 64% YTD as the effects of an accounting scandal are still being felt.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367467-roadrunner-transportation-systems-6_2-percent-post-q1-results\" target=\"_blank\">Roadrunner Transportation Systems up 6.2% post Q1 results</a> (July 2)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3367549\" data-linked=\"Roadrunner Transportation soars after business update\" data-tweet=\"$RRTS - Roadrunner Transportation soars after business update https://seekingalpha.com/news/3367549-roadrunner-transportation-soars-after-business-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3367549-roadrunner-transportation-soars-after-business-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367542\" data-ts=\"1530550841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367542-financials-top-5-gainers-losers-of-1-00-pm-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (07/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PFBC' title='Preferred Bank'>PFBC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ELVT' title='Elevate Credit'>ELVT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> DDR <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal'>HCC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco FrancÃ©s S.A.  ADR'>BFR</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GEC' title='Great Elm Capital Group, Inc.'>GEC</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367542\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (07/02/2018)\" data-tweet=\"$CLDC $CLDC $GROW - Financials - Top 5 Gainers / Losers as of 1:00 PM (07/02/2018) https://seekingalpha.com/news/3367542-financials-top-5-gainers-losers-of-1-00-pm-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367542-financials-top-5-gainers-losers-of-1-00-pm-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367541\" data-ts=\"1530550723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367541-midday-gainers-losers-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (07/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+153%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+54%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/BASI' title='Bioanalytical Systems, Inc.'>BASI</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/DAC' title='Danaos Corporation'>DAC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a> <font color='red'>-38%</font>. <a href='https://seekingalpha.com/symbol/ALV' title='Autoliv Inc.'>ALV</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/NEWA' title='Newater Technology, Inc.'>NEWA</a> <font color='red'>-23%</font>. DDR <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/TKAT' title='Takung Art Co., Ltd.'>TKAT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SPCB' title='SuperCom, Ltd.'>SPCB</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367541\" data-linked=\"Midday Gainers / Losers (07/02/2018)\" data-tweet=\"$GBR $GBR $SAEX - Midday Gainers / Losers (07/02/2018) https://seekingalpha.com/news/3367541-midday-gainers-losers-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367541-midday-gainers-losers-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367540\" data-ts=\"1530550639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367540-melco-resorts-leading-decliner-in-macau-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Melco Resorts a leading decliner in Macau sell-off</a></h4><ul> <li>Shares of Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) are <font color='red'>down 9.60%</font> to their lowest level of 2018 after industry-wide June Macau gross gaming revenue numbers were reported below expectations (+12% vs. +18% consensus).</li> <li>Some traders see the move as overdone with Macau posting a streak of 23 straight months of revenue gains and topping +20% growth for several months this year. Melco is also coming off a quarter of record adjusted EBITDA.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3367313-macau-casino-revenue-cools-june\" target=\"_blank\">Macau casino revenue cools off in June</a> (July 1)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367387-macau-sector-slides-june-ggr-disappoints\" target=\"_blank\">Macau sector slides after June GGR disappoints</a> (July 2)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3367540\" data-linked=\"Melco Resorts a leading decliner in Macau sell-off\" data-tweet=\"$MLCO - Melco Resorts a leading decliner in Macau sell-off https://seekingalpha.com/news/3367540-melco-resorts-leading-decliner-in-macau-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3367540-melco-resorts-leading-decliner-in-macau-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367533\" data-ts=\"1530548964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLPH\" target=\"_blank\">DLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367533-jittery-trading-on-auto-supplier-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jittery trading on auto supplier stocks</a></h4><ul> <li>Auto supplier stocks are down amid more anxiety over the tariff battles between the U.S. and EU nations, China, Canada and Mexico.</li> <li>The automobile industry is particularly sensitive to tariff wildcards due to the lengthy advance time on purchasing and manufacturing decisions.</li> <li>Notable decliners include Delphi Technologies (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='red'>-2.8%</font>), Modine Manufacturing (<a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a> <font color='red'>-3.3%</font>), WABCO Holdings (<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a> <font color='red'>-2.5%</font>), Visteon (<a href='https://seekingalpha.com/symbol/VC' title='Visteon Corporation'>VC</a> <font color='red'>-2.7%</font>), Workhorse Group (<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-2.7%</font>), Allison Transmission (<a href='https://seekingalpha.com/symbol/ALSN' title='Allison Transmission'>ALSN</a> <font color='red'>-2.1%</font>), Cooper-Standard (<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a> <font color='red'>-2.1%</font>) and Aptiv (<a href='https://seekingalpha.com/symbol/APTV' title='Aptiv PLC'>APTV</a> <font color='red'>-1.4%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3367533\" data-linked=\"Jittery trading on auto supplier stocks\" data-tweet=\"$DLPH $DLPH $MOD - Jittery trading on auto supplier stocks https://seekingalpha.com/news/3367533-jittery-trading-on-auto-supplier-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3367533-jittery-trading-on-auto-supplier-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367529\" data-ts=\"1530548590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VDNRF\" target=\"_blank\">VDNRF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367529-vedanta-resources-chairmans-family-trust-to-buy-rest-of-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vedanta Resources chairman&#39;s family trust to buy rest of company</a></h4><ul>     <li>Vedanta Resources (<a href='https://seekingalpha.com/symbol/VDNRF' title='Vedanta Resources plc.'>OTCPK:VDNRF</a> <font color='green'>+25.8%</font>) surges in London trading after chairman Anil Agarwal&rsquo;s family trust <a href=\"https://timesofindia.indiatimes.com/business/india-business/anil-agarwal-to-delist-vedanta-resources-from-london-stock-exchange/articleshow/64825933.cms\" target=\"_blank\">agrees to acquire</a> the rest of the company it does not already own in a deal that values the mining conglomerate at &pound;2.3B ($3.03B).</li>     <li>Agarwal's Volcan Investments, which currently holds 66.53% of Vedanta, made a cash offer for 825 pence per share, a 27.6% premium to Friday's closing price of 646.8 pence.</li><li>After delisting of Vedanta Resources, Agarwal would have just two listed  companies in India: Vedanta Ltd. - which contains his sprawling copper,  silver, lead, iron ore, power, aluminum mining and oil and gas - and  Hindustan Zinc.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367529\" data-linked=\"Vedanta Resources chairman&#39;s family trust to buy rest of company\" data-tweet=\"$VDNRF - Vedanta Resources chairman&#39;s family trust to buy rest of company https://seekingalpha.com/news/3367529-vedanta-resources-chairmans-family-trust-to-buy-rest-of-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3367529-vedanta-resources-chairmans-family-trust-to-buy-rest-of-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367528\" data-ts=\"1530548371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGN\" target=\"_blank\">ALGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367528-align-tech-prevails-in-legal-challenge-to-invisalign-store-pilot-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Align Tech prevails in legal challenge to Invisalign store pilot program</a></h4><ul><li>Align Technology (<a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a> <font color='red'>-1.7%</font>) has <a href=\"https://seekingalpha.com/pr/17206376-align-technology-provides-update-regarding-smiledirectclub-sdc-dispute\" target=\"_blank\">won the first round</a> in a legal spat between the company and SDC Financial LLC and SmileDirectClub LLC regarding its Invisalign stores.</li><li>The plaintiffs allege that Align's pilot program breaches non-compete provisions that apply to members of SDC Financial LLC. Remedies requested include the preliminary and permanent enjoinment of all activities related to the pilot program, including the closure of all Invisalign stores and a prohibition on opening new stores, and allowing SDC entities to exercise their right to repurchase all of Align's SDC Financial LLC membership interests at a price equal to Align's current capital account balance.</li><li>On Friday, June 29, a Tennessee court denied the SDC entities' request for a temporary injunction preventing Align from opening new stores. The company says it intends to continue the pilot program and will \"vigorously defend itself\" in arbitration proceedings currently scheduled for December 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367528\" data-linked=\"Align Tech prevails in legal challenge to Invisalign store pilot program\" data-tweet=\"$ALGN - Align Tech prevails in legal challenge to Invisalign store pilot program https://seekingalpha.com/news/3367528-align-tech-prevails-in-legal-challenge-to-invisalign-store-pilot-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3367528-align-tech-prevails-in-legal-challenge-to-invisalign-store-pilot-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367524\" data-ts=\"1530547892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367524-nyp-cavs-owner-robbins-in-group-bidding-for-si\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYP: Cavs owner, Robbins in group bidding for SI</a></h4><ul>   <li>A consortium including Velocity Group's Joshua Pollack, Cleveland Cavaliers owner Dan Gilbert and motivational speaker Tony Robbins are <a href=\"https://nypost.com/2018/07/01/cavs-owner-is-latest-interested-buyer-for-sports-illustrated/\" target=\"_blank\">bidding for <i>Sports Illustrated</i></a><i>,</i> the <i>New York Post</i> says.</li>    <li>That's ahead of a 5 p.m. deadline for bids for the venerable magazine brand, one of several former Time Inc. titles being unloaded by Meredith (<a href=\"http://seekingalpha.com/symbol/MDP\" target=\"_blank\">MDP</a> <font color='green'>+2.1%</font>) after it acquired Time.</li>    <li>Meredith is reportedly hoping for $200M in a sale of <em>SI.</em></li>    <li>The Pollack group is also said to be interested in the bidding for <i>Fortune</i> and <i>Money</i> (bids for those were due June 29).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367524\" data-linked=\"NYP: Cavs owner, Robbins in group bidding for SI\" data-tweet=\"$MDP - NYP: Cavs owner, Robbins in group bidding for SI https://seekingalpha.com/news/3367524-nyp-cavs-owner-robbins-in-group-bidding-for-si?source=tweet\" data-url=\"https://seekingalpha.com/news/3367524-nyp-cavs-owner-robbins-in-group-bidding-for-si\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367523\" data-ts=\"1530547745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367523-new-concept-energy-doubles-extending-recent-run-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Concept Energy more than doubles, extending recent run-up</a></h4><ul>     <li>Volatile New Concept Energy (<a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+158.1%</font>) skyrockets to its highest levels in 16 years, with <a href=\"https://www.marketwatch.com/story/micro-cap-new-concept-energy-shares-soar-172-2018-07-02\" target=\"_blank\">no apparent news</a> to explain the move.</li>     <li>The stock closed at just $1.42 as recently as last Wednesday; it has gained 754% in the last month and 669% YTD.</li>     <li>GBR has properties in the Appalachian Basin and Utica Basin, and its <a href=\"http://www.newconceptenergy.com/\" target=\"_blank\">website says</a> it is \"looking to acquire controlling interest in several projects.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367523\" data-linked=\"New Concept Energy more than doubles, extending recent run-up\" data-tweet=\"$GBR - New Concept Energy more than doubles, extending recent run-up https://seekingalpha.com/news/3367523-new-concept-energy-doubles-extending-recent-run-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3367523-new-concept-energy-doubles-extending-recent-run-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367519\" data-ts=\"1530547248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRFS\" target=\"_blank\">BRFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367519-consumer-top-5-gainers-losers-of-12-00-pm-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (07/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PERY' title='Perry Ellis International Inc.'>PERY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RIBT' title='RiceBran Technologies'>RIBT</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ALV' title='Autoliv Inc.'>ALV</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367519\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (07/02/2018)\" data-tweet=\"$BRFS $BRFS $PETZ - Consumer - Top 5 Gainers / Losers as of 12:00 PM (07/02/2018) https://seekingalpha.com/news/3367519-consumer-top-5-gainers-losers-of-12-00-pm-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367519-consumer-top-5-gainers-losers-of-12-00-pm-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367518\" data-ts=\"1530547059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367518-nike-down-nearly-3-federer-exits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike down nearly 3% as Federer exits</a></h4><ul><li>The all-time great <a href=\"https://www.bloomberg.com/news/articles/2018-07-02/roger-federer-leaves-nike-for-uniqlo-in-blockbuster-deal?utm_medium=social&amp;cmpid%3D=socialflow-twitter-markets&amp;utm_source=twitter&amp;utm_content=markets&amp;utm_campaign=socialflow-organic\" target=\"_blank\">walked onto Center Court Wimbledon today</a> in an outfit by Japan's Uniqlo. His contract with Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='red'>-2.8%</font>) had expired on March 1.</li><li>Terms of Federer's deal with Uniqlo weren't disclosed, but ESPN is reporting a guarantee of $300M over 10 years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367518\" data-linked=\"Nike down nearly 3% as Federer exits\" data-tweet=\"$NKE - Nike down nearly 3% as Federer exits https://seekingalpha.com/news/3367518-nike-down-nearly-3-federer-exits?source=tweet\" data-url=\"https://seekingalpha.com/news/3367518-nike-down-nearly-3-federer-exits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367517\" data-ts=\"1530546803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367517-ft-conoco-s-redeployment-out-of-permian-only-temporary-lance-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FT: Conoco\u2019s redeployment out of Permian only temporary, Lance says</a></h4><ul><li>ConocoPhillips (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-1.2%</font>)&nbsp;CEO&nbsp;Ryan Lance said last month that the company was looking at redeploying resources out of the Permian Basin because of the shortage of pipeline capacity in Texas, but he tells <em>Financial Times</em> that the action is <a href=\"https://www.ft.com/content/dd0b8bee-7d30-11e8-8e67-1e1a0846c475\" target=\"_blank\">only a temporary delay</a> after the company was taken by surprise by how quickly the pipelines for taking oil out of the region had filled up.</li><li>COP does not have firm commitments for pipeline capacity to take its oil from the Permian Basin to refineries or export terminals, and has needed to book space on pipelines as available, which has caused it to think about slowing down the rate at which it is drilling and completing wells in the Permian.</li><li>While Lance is \"not sure it makes sense to drill into that headwind,\" he also wants to keep working in the Permian to learn about how to operate there, so that &ldquo;when we&rsquo;re ready to go into full manufacturing mode, we&rsquo;re there and we&rsquo;re optimized.\"</li><li>If COP does redeploy resources, they would not go out of the U.S. but to other shale oil regions such as the Eagle Ford of south Texas or the Bakken of North Dakota, where it has transport facilities booked and can secure better prices for its production.</li><li>The CEO says activity in the Permian could be ramped back up again as new pipelines are built, adding 1.5M-2M of new takeaway capacity by early 2020, some of which COP has booked for its expected production.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367517\" data-linked=\"FT: Conoco\u2019s redeployment out of Permian only temporary, Lance says\" data-tweet=\"$COP - FT: Conoco\u2019s redeployment out of Permian only temporary, Lance says https://seekingalpha.com/news/3367517-ft-conoco-s-redeployment-out-of-permian-only-temporary-lance-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3367517-ft-conoco-s-redeployment-out-of-permian-only-temporary-lance-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367516\" data-ts=\"1530546720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTC-USD\" target=\"_blank\">BTC-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367516-big-bounce-for-cryptos-gbtc-up-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big bounce for cryptos; GBTC up 16%</a></h4><ul><li>Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) plunged to as low as about $5.7K late last week, but has returned to $6.6K at current check,&nbsp;<font color='green'>up 5%</font>&nbsp;on today's session. Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>), Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>), and Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>) have bounced similar amounts.</li><li><a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>&nbsp;<font color='green'>+16.5%</font></li><li>The <em>WSJ</em> has an interesting pice<a href=\"https://www.wsj.com/articles/look-out-bitcoin-has-lost-its-tether-1530477448\" target=\"_blank\"> from Andy Kessler</a>, tracing Bitcoin's meteoric rise to Tether (<a href='https://seekingalpha.com/symbol/USDT-USD' title='Tether USD'>USDT-USD</a>). Fixed at $1, more Tether needed to be issued as the price of Bitcoin rose. Proceeds from said issuance were plowed in Bitcoin. Rinse. Repeat. Trouble began, though, when Bitcoin's inevitable rise became less so.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367516\" data-linked=\"Big bounce for cryptos; GBTC up 16%\" data-tweet=\"$BTC-USD $BTC-USD $ETH-USD - Big bounce for cryptos; GBTC up 16% https://seekingalpha.com/news/3367516-big-bounce-for-cryptos-gbtc-up-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3367516-big-bounce-for-cryptos-gbtc-up-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367514\" data-ts=\"1530546637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOMO\" target=\"_blank\">DOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367514-domominus-11-on-second-day-of-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Domo -11% on second day of trading</a></h4><ul><li>        Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>) closed its rocky first day of trading on Friday&nbsp;<font color='green'>up 30%</font>&nbsp;to $27.30. The analytics company has lost some of those gains today with shares currently&nbsp;<font color='red'>down 11%</font>&nbsp;to $24.34.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367196-domo-plus-13-percent-open-first-trading-day\" target=\"_blank\">Domo +13% on open of first trading day</a> (June 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367514\" data-linked=\"Domo -11% on second day of trading\" data-tweet=\"$DOMO - Domo -11% on second day of trading https://seekingalpha.com/news/3367514-domominus-11-on-second-day-of-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/3367514-domominus-11-on-second-day-of-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367509\" data-ts=\"1530545994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUPN\" target=\"_blank\">SUPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367509-piper-on-fence-volume-growth-of-supernus-pharmas-trokendi-xr-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper on the fence with volume growth of Supernus Pharma&#39;s Trokendi XR; shares down 5%</a></h4><ul><li>Supernus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/SUPN' title='Supernus Pharmaceuticals, Inc.'>SUPN</a> <font color='red'>-4.7%</font>) slips on below-average volume on the heels of a note from Piper Jaffray's David Amsellem (Neutral/$47) stating that the results from an in-house survey of 25 neurologists suggested weakening volume growth for top seller Trokendi XR which accounted for 77% of the company's 2017 product sales ($226.5M/294.1M).</li><li>Mr. Amsellem adds that the significance of the pressure on volume/sales growth is \"unclear\" but he believes Trokendi XR will not be a significant revenue growth drive in the coming years.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3367509\" data-linked=\"Piper on the fence with volume growth of Supernus Pharma&#39;s Trokendi XR; shares down 5%\" data-tweet=\"$SUPN - Piper on the fence with volume growth of Supernus Pharma&#39;s Trokendi XR; shares down 5% https://seekingalpha.com/news/3367509-piper-on-fence-volume-growth-of-supernus-pharmas-trokendi-xr-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3367509-piper-on-fence-volume-growth-of-supernus-pharmas-trokendi-xr-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367502\" data-ts=\"1530545162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGL\" target=\"_blank\">MDGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367502-nash-players-in-green-potential-deals-loom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nash players in the green as potential deals loom</a></h4><ul><li>Certain companies developing treatments for nonalcoholic steatohepatitis &#40;NASH&#41; continue to see positive money flow as bullish investors see continued upside and expected M&amp;A activity.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+5%</font>)(<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+2.3%</font>)(<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='green'>+2%</font>)(<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+2.3%</font>)(<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+2.1%</font>)(<a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+4.2%</font>)(<a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit'>OTCPK:GNFTF</a>)(<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+0.9%</font>)(<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='green'>+1.6%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367502\" data-linked=\"Nash players in the green as potential deals loom\" data-tweet=\"$MDGL $MDGL $VKTX - Nash players in the green as potential deals loom https://seekingalpha.com/news/3367502-nash-players-in-green-potential-deals-loom?source=tweet\" data-url=\"https://seekingalpha.com/news/3367502-nash-players-in-green-potential-deals-loom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>99&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367501\" data-ts=\"1530544419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367501-cti-bios-mid-stage-study-of-pacritinib-in-myelofibrosis-to-continue-planned-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CTI Bio&#39;s mid-stage study of pacritinib in myelofibrosis to continue as planned; shares up 3%</a></h4><ul><li>Thinly traded micro cap CTI BioPharma (<a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+2.6%</font>) is up on below-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17206603-cti-biopharma-announces-continuation-without-modification-pac203-phase-2-study-pacritinib\" target=\"_blank\">announcement </a>that its Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03165734?lead=cti+biopharma&amp;phase=1&amp;rank=1\" target=\"_blank\">PAC203</a>, assessing JAK2 inhibitor pacritinib in myelofibrosis patients previously treated with Incyte's Jakafi (ruxolitinib) will continue as planned without modification.</li><li>Enrollment of up to 150 subjects should be completed before year-end.</li><li>The primary endpoint of the open-label dose-finding study is the percent reduction in spleen volume from baseline at week 24.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367501\" data-linked=\"CTI Bio&#39;s mid-stage study of pacritinib in myelofibrosis to continue as planned; shares up 3%\" data-tweet=\"$CTIC - CTI Bio&#39;s mid-stage study of pacritinib in myelofibrosis to continue as planned; shares up 3% https://seekingalpha.com/news/3367501-cti-bios-mid-stage-study-of-pacritinib-in-myelofibrosis-to-continue-planned-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3367501-cti-bios-mid-stage-study-of-pacritinib-in-myelofibrosis-to-continue-planned-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367499\" data-ts=\"1530544375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRSN\" target=\"_blank\">VRSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367499-verisign-up-on-price-target-boosts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VeriSign up on price target boosts</a></h4><ul><li>        Cowen <a href=\"https://www.streetinsider.com/Analyst+Comments/VeriSign+%28VRSN%29+PT+Raised+to+%24135+at+Cowen/14362290.html\" target=\"_blank\">raises</a> its VeriSign (NASDAQ:<a href='https://seekingalpha.com/symbol/VRSN' title='VeriSign, Inc.'>VRSN</a>) price target from $120 to $135, a 2% downside to Friday&rsquo;s close.</li><li>        Rating maintained at Market Perform.</li><li>               More action: JPMorgan <a href=\"https://www.marketwatch.com/investing/stock/VRSN?siteid=rss&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A%20marketwatch%2Frealtimeheadlines%20%28MarketWatch.com%20-%20Real-time%20Headlines%29\" target=\"_blank\">raises</a> its VeriSign target from $107 to $122. &nbsp;&nbsp;</li><li>               VeriSign shares are&nbsp;<font color='green'>up 0.7%</font>&nbsp;to $138.38.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3367499\" data-linked=\"VeriSign up on price target boosts\" data-tweet=\"$VRSN - VeriSign up on price target boosts https://seekingalpha.com/news/3367499-verisign-up-on-price-target-boosts?source=tweet\" data-url=\"https://seekingalpha.com/news/3367499-verisign-up-on-price-target-boosts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367498\" data-ts=\"1530544161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAMP\" target=\"_blank\">RAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367498-acxiomplus-11_5-interpublic-reportedly-nears-2_2b-unit-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acxiom +11.5% as Interpublic reportedly nears $2.2B unit deal</a></h4><ul>   <li>Acxiom (NYSE:<a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a>) is <font color='green'>up 11.5%</font> today after a Reuters report suggests Interpublic Group (<a href=\"http://seekingalpha.com/symbol/IPG\" target=\"_blank\">IPG</a> <font color='red'>-2.4%</font>) is <a href=\"https://www.reuters.com/article/us-acxiom-m-a/exclusive-interpublic-near-deal-to-buy-acxiom-marketing-solutions-unit-for-around-2-2-billion-idUSKBN1JR25Y\" target=\"_blank\">nearing a $2.2B deal</a> to buy Acxiom's marketing solutions division.</li>    <li>Shares had <a href=\"https://seekingalpha.com/news/3366927-acxiom-plus-3_5-percent-1_5b-bids-seen-data-unit\" target=\"_blank\">moved up Thursday</a> with speculation growing about bids that could top $1.5B. A $2.2B deal for the data-marketing unit is almost more than Acxiom's market cap last week of $2.3B.</li>    <li>Acxiom's part in a deal that would sell off about three-quarters of its revenue is to focus on a faster growing area, its LiveRamp unit.</li>    <li>And Acxiom is expected to eventually explore a sale of its remaining business.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367498\" data-linked=\"Acxiom +11.5% as Interpublic reportedly nears $2.2B unit deal\" data-tweet=\"$RAMP $RAMP $IPG - Acxiom +11.5% as Interpublic reportedly nears $2.2B unit deal https://seekingalpha.com/news/3367498-acxiomplus-11_5-interpublic-reportedly-nears-2_2b-unit-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3367498-acxiomplus-11_5-interpublic-reportedly-nears-2_2b-unit-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367497\" data-ts=\"1530544080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367497-wells-fargo-gets-upgrade-from-morgan-stanley-after-feds-stress-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo gets upgrade from Morgan Stanley after Fed&#39;s stress test</a></h4><ul><li>Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='green'>+0.6%</font>) <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/07/11964102/fed-stress-test-shows-wells-fargos-main-overhang-is-gon\" target=\"_blank\">upgraded by Morgan Stanley analyst </a>Betsy Graseck&nbsp; to equal-weight from underweight and boosted her price target to $62 from $57.</li><li>The upgrade comes after WFC passed the second half ot the Fed's annual stress tests for banks and announced plans to increase its Q3 dividend to 43 cents a share from 39 cents and buy back as much as $24.5B of its stock, more than double its 2017 stock repurchase program.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367028-jpmorgan-wells-fargo-american-express-citi-report-dividend-boosts-buybacks\" target=\"_blank\">JPMorgan, Wells Fargo, American Express, Citi report dividend boosts, buybacks</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367497\" data-linked=\"Wells Fargo gets upgrade from Morgan Stanley after Fed&#39;s stress test\" data-tweet=\"$WFC - Wells Fargo gets upgrade from Morgan Stanley after Fed&#39;s stress test https://seekingalpha.com/news/3367497-wells-fargo-gets-upgrade-from-morgan-stanley-after-feds-stress-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3367497-wells-fargo-gets-upgrade-from-morgan-stanley-after-feds-stress-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367491\" data-ts=\"1530543636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMP\" target=\"_blank\">ADMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367491-healthcare-top-5-gainers-losers-of-11-00-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/02/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367491\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/02/2018)\" data-tweet=\"$ADMP $ADMP $BLFS - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/02/2018) https://seekingalpha.com/news/3367491-healthcare-top-5-gainers-losers-of-11-00-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367491-healthcare-top-5-gainers-losers-of-11-00-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367490\" data-ts=\"1530543582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367490-neovasc-files-for-100m-mixed-shelf-offering-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc files for $100M mixed shelf offering; shares up 3%</a></h4><ul><li>Neovasc (<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='green'>+2.6%</font>) has filed a <a href=\"https://seekingalpha.com/pr/17206625-neovasc-announces-filing-shelf-prospectus-form-fminus-10-registration-statement\" target=\"_blank\">preliminary prospectus</a> for a $100M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367490\" data-linked=\"Neovasc files for $100M mixed shelf offering; shares up 3%\" data-tweet=\"$NVCN - Neovasc files for $100M mixed shelf offering; shares up 3% https://seekingalpha.com/news/3367490-neovasc-files-for-100m-mixed-shelf-offering-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3367490-neovasc-files-for-100m-mixed-shelf-offering-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367487\" data-ts=\"1530543255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYMX\" target=\"_blank\">MYMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367487-nymox-boost-marketing-plans-for-bph-med-fexapotide-triflutate-in-europe-shares-up-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nymox boost marketing plans for BPH med fexapotide triflutate in Europe; shares up 8%</a></h4><ul><li>Thinly traded micro cap Nymox (<a href='https://seekingalpha.com/symbol/MYMX' title='Mymetics Corp.'>OTCQB:MYMX</a> <font color='green'>+7.8%</font>) is up on 25% higher volume in response to its <a href=\"https://seekingalpha.com/pr/17206947-nymox-announces-expanded-marketing-plans\" target=\"_blank\">announcement</a> of expanded marketing plans in Europe for fexapotide triflutate for the treatment of benign prostatic hyperplasia &#40;BPH&#41;, or enlarged prostate. The broader commercial plan was enabled by a ramp-up in production to 50 g per batch (equivalent to 18K - 20K units of 2.5 mg).</li><li>The company says it expects to file a new marketing application in Europe replacing its prior application.</li><li>A U.S. marketing application is on tap for later this year.</li><li>Long-term shareholders recently invested an additional $18.25M in the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367487\" data-linked=\"Nymox boost marketing plans for BPH med fexapotide triflutate in Europe; shares up 8%\" data-tweet=\"$MYMX - Nymox boost marketing plans for BPH med fexapotide triflutate in Europe; shares up 8% https://seekingalpha.com/news/3367487-nymox-boost-marketing-plans-for-bph-med-fexapotide-triflutate-in-europe-shares-up-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3367487-nymox-boost-marketing-plans-for-bph-med-fexapotide-triflutate-in-europe-shares-up-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367486\" data-ts=\"1530542769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367486-ge-still-significantly-overvalued-j-p-morgans-tusa-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE still &#39;significantly overvalued,&#39; J.P. Morgan&#39;s Tusa says</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-2.6%</font>) slumps in early trading as longtime bear Stephen Tusa <a href=\"https://www.thestreet.com/investing/core-ge-remains-significantly-overvalued-j-p-morgan-says-14639827\" target=\"_blank\">reiterates his Underweight rating</a> and $11 price target on the stock, saying the company's turnaround strategy will not lead to a higher price.</li>     <li>The J.P. Morgan analyst says GE remains \"significantly overvalued\" after recent asset sales based on his sum-of-the-parts analysis: \"At the current roughly $14 stock price, we calculate [the remaining company] needs to support ~$11 of value on the back of what we see as $0.40/$0.33 in EPS/[free cash flow] in 2019.\"</li><li>Tusa, who has been Underweight on GE since May 2016, sees \"a reasonable bear  case that... would imply $6 [per share] for [the remaining company] and a  price target of $9.\"</li>     <li>\"We still see structural concerns in the key Power&nbsp;markets, minimal margin for error on leverage, numerous tail liabilities at both GE and [GE Capital Services],\" Tusa writes. \"Perhaps not&nbsp;well understood is that 2019 is shaping up to be much like 2018, with management now messaging no decline&nbsp;in cash restructuring and only a modest decline in book restructuring.\"</li>     <li>Just <a href=\"https://seekingalpha.com/news/3367242-ge-bear-tusa-predicts-dividend-cut-30-percent-plus-range\" target=\"_blank\">last week</a>, Tusa was out predicting GE's dividend will be cut \"precipitously,\" perhaps in the \"30%-plus range,\" by the end of 2019.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3367486\" data-linked=\"GE still &#39;significantly overvalued,&#39; J.P. Morgan&#39;s Tusa says\" data-tweet=\"$GE - GE still &#39;significantly overvalued,&#39; J.P. Morgan&#39;s Tusa says https://seekingalpha.com/news/3367486-ge-still-significantly-overvalued-j-p-morgans-tusa-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3367486-ge-still-significantly-overvalued-j-p-morgans-tusa-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>209&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367483\" data-ts=\"1530542475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAND\" target=\"_blank\">BAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367483-bandwidthminus-2_5-morgan-stanley-backs-off-to-equal-weight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bandwidth -2.5% as Morgan Stanley backs off to Equal Weight</a></h4><ul>   <li>Bandwidth (NASDAQ:<a href='https://seekingalpha.com/symbol/BAND' title='Bandwidth, Inc.'>BAND</a>) is <font color='red'>2.5% lower</font> after a cut to Equal Weight by Morgan Stanley.</li>    <li>The firm still sees Bandwidth as a leader in CPaaS, but there's near-term dislocation after a 90% gain from the November IPO. The carrier is unlikely to see the big beats it needs to close a gap with peers until mid-2019 at the earliest. (h/t Bloomberg)</li>    <li>It's maintaining a price target of $40, now 8% upside from the currently lower price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367483\" data-linked=\"Bandwidth -2.5% as Morgan Stanley backs off to Equal Weight\" data-tweet=\"$BAND - Bandwidth -2.5% as Morgan Stanley backs off to Equal Weight https://seekingalpha.com/news/3367483-bandwidthminus-2_5-morgan-stanley-backs-off-to-equal-weight?source=tweet\" data-url=\"https://seekingalpha.com/news/3367483-bandwidthminus-2_5-morgan-stanley-backs-off-to-equal-weight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367480\" data-ts=\"1530542006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUN\" target=\"_blank\">RUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367480-sunrunplus-3_2-on-target-boost-to-67-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunrun +3.2% on target boost to 67% upside</a></h4><ul><li>        Credit Suisse <a href=\"https://www.streetinsider.com/Analyst+Comments/Sunrun+%28RUN%29+PT+Raised+to+%2422+at+Credit+Suisse/14362918.html\" target=\"_blank\">maintains</a> an Outperform rating on Sunrun (NASDAQ:<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a>) and raises the price target from $16 to $22, a 67% upside to Friday&rsquo;s close.</li><li>               Sunrun shares are&nbsp;<font color='green'>up 3.2%</font>&nbsp;to $13.57.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3367480\" data-linked=\"Sunrun +3.2% on target boost to 67% upside\" data-tweet=\"$RUN - Sunrun +3.2% on target boost to 67% upside https://seekingalpha.com/news/3367480-sunrunplus-3_2-on-target-boost-to-67-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3367480-sunrunplus-3_2-on-target-boost-to-67-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367478\" data-ts=\"1530541974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BASI\" target=\"_blank\">BASI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367478-bioanalytical-systems-acquires-seventh-wave-labs-for-cash-and-stock-shares-up-34\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bioanalytical Systems acquires Seventh Wave Labs for cash and stock; shares up 34%</a></h4><ul><li>Thinly traded nano cap Bioanalytical Systems (<a href='https://seekingalpha.com/symbol/BASI' title='Bioanalytical Systems, Inc.'>BASI</a> <font color='green'>+33.9%</font>) is up on whopping 83x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17206872-basi-seventh-wave-laboratories-combine-operations-provide-broader-solutions-greater\" target=\"_blank\">announced asset purchase dea</a>l with Seventh Wave Laboratories, a provider of integrated services aimed at assessing the safety and efficacy of pharmaceuticals and medical devices that generated ~$11M in sales last year.</li><li>Under the terms of the agreement, BASI will issue 1.5M shares of its common stock and pay $7M in cash for all Seventh Wave assets.</li><li>To finance the cash portion, BASI borrowed $5.5M from First Internet Bank and increased its credit line to $3.5M from $2.0M.</li><li>When the transaction closes, Seventh Wave will own ~17% of BASI's common stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367478\" data-linked=\"Bioanalytical Systems acquires Seventh Wave Labs for cash and stock; shares up 34%\" data-tweet=\"$BASI - Bioanalytical Systems acquires Seventh Wave Labs for cash and stock; shares up 34% https://seekingalpha.com/news/3367478-bioanalytical-systems-acquires-seventh-wave-labs-for-cash-and-stock-shares-up-34?source=tweet\" data-url=\"https://seekingalpha.com/news/3367478-bioanalytical-systems-acquires-seventh-wave-labs-for-cash-and-stock-shares-up-34\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367471\" data-ts=\"1530541473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367471-finjanplus-2_1-on-trend-micro-patent-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan +2.1% on Trend Micro patent agreement</a></h4><ul><li>           Finjan (NASDAQ:<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a>) and Trend Micro (<a href='https://seekingalpha.com/symbol/TMICF' title='Trend Micro Inc.'>OTCPK:TMICF</a>) <a href=\"https://seekingalpha.com/pr/17206777-finjan-trend-micro-enter-confidential-patent-license-agreement\" target=\"_blank\">enter</a> an ongoing license agreement that gives Trend Micro access to Finjan&rsquo;s broad cybersecurity patent portfolio. </li><li> Finjan can transfer select security-related patent assets from Trend Micro. </li><li> Both parties also gain more limited access to the other&rsquo;s patent portfolio for an unspecified number of years. </li><li> Finjan shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;to $3.47.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3367471\" data-linked=\"Finjan +2.1% on Trend Micro patent agreement\" data-tweet=\"$FNJN $FNJN $TMICF - Finjan +2.1% on Trend Micro patent agreement https://seekingalpha.com/news/3367471-finjanplus-2_1-on-trend-micro-patent-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3367471-finjanplus-2_1-on-trend-micro-patent-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367470\" data-ts=\"1530541151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTI\" target=\"_blank\">FTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367470-technipfmc-wins-subsea-contract-for-total-s-zinia-2-field\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TechnipFMC wins subsea contract for Total\u2019s Zinia 2 field</a></h4><ul>     <li>TechnipFMC (<a href='https://seekingalpha.com/symbol/FTI' title='TechnipFMC plc'>FTI</a> <font color='red'>-2.9%</font>) is <a href=\"https://www.epmag.com/technipfmc-lands-subsea-contract-totals-zinia-2-field-1707791\" target=\"_blank\">awarded a contract</a> by Total (<a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a> <font color='red'>-0.2%</font>) for the Zinia Phase 2 field development in Block 17 offshore Angola; financial details are not provided.</li>     <li>FTI says the contract covers the engineering, procurement and construction of subsea equipment including nine subsea tree units as well as wellheads, subsea control systems, connection systems and associated equipment.</li>     <li>TOT made the final investment decision on the project <a href=\"https://seekingalpha.com/news/3360065-total-sonangol-reach-deals-help-boost-angola-oil-production\" target=\"_blank\">last month</a>; TOT is operator of Block 17 with a 40% interest.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367470\" data-linked=\"TechnipFMC wins subsea contract for Total\u2019s Zinia 2 field\" data-tweet=\"$FTI $FTI $TOT - TechnipFMC wins subsea contract for Total\u2019s Zinia 2 field https://seekingalpha.com/news/3367470-technipfmc-wins-subsea-contract-for-total-s-zinia-2-field?source=tweet\" data-url=\"https://seekingalpha.com/news/3367470-technipfmc-wins-subsea-contract-for-total-s-zinia-2-field\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367466\" data-ts=\"1530540992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367466-mabvax-bails-on-plan-to-regain-compliance-nasdaq-listing-requirements-shares-down-45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax bails on plan to regain compliance with Nasdaq listing requirements; shares down 45%</a></h4><ul><li>Thinly traded nano cap MabVax Therapeutics Holdings (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-44.8%</font>) slumps on more than double normal volume, albeit on turnover of only 169K shares, in response to its <a href=\"https://seekingalpha.com/pr/17206765-mabvax-therapeutics-decides-submit-plan-regain-compliance-nasdaq-listing-standards\" target=\"_blank\">announcement </a>that it will not submit a plan to Nasdaq to regain compliance with listing requirements related to its yet-to-filed Q1 10-Q.</li><li>Several months ago, the company announced that its financial statements for years 2014-2017 could no longer be relied upon due to issues related to the ownership of preferred stock and whether certain investors acted as an undisclosed group in acquiring shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358281-mabvax-27-percent-accuracy-issues-prior-financials\" target=\"_blank\">MabVax down 27% on accuracy issues in prior financials</a> (May 21)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345633-mabvax-receives-listing-deficiency-notice-nasdaq\" target=\"_blank\">MabVax receives listing deficiency notice from Nasdaq</a> (April 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367466\" data-linked=\"MabVax bails on plan to regain compliance with Nasdaq listing requirements; shares down 45%\" data-tweet=\"$MBVX $MBVXQ - MabVax bails on plan to regain compliance with Nasdaq listing requirements; shares down 45% https://seekingalpha.com/news/3367466-mabvax-bails-on-plan-to-regain-compliance-nasdaq-listing-requirements-shares-down-45?source=tweet\" data-url=\"https://seekingalpha.com/news/3367466-mabvax-bails-on-plan-to-regain-compliance-nasdaq-listing-requirements-shares-down-45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367467\" data-ts=\"1530540958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRTS\" target=\"_blank\">RRTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367467-roadrunner-transportation-systems-up-6_2-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roadrunner Transportation Systems up 6.2% post Q1 results</a></h4><ul><li>Roadrunner Transportation Systems (<a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a> <font color='green'>+6.2%</font>) <a href=\"https://seekingalpha.com/filing/4086240\" target=\"_blank\">reports Q1</a> revenue growth of 19% to $570M.</li><li>Segment revenue: TES increased 43.3% Y/Y to&nbsp;$326.1M,&nbsp; due to an increase in ground and air expedited freight business which drove higher volumes and rates; LTL increased 4% Y/Y to $113.1M&nbsp;due to higher fuel surcharges and rates, partially offset by lower shipments where as Ascent decreased 25.1% Y/Y to&nbsp;$13.4M&nbsp;due to the divestiture of Unitrans.</li><li>Segment Adj. EBITDA: TES&nbsp;<font color='green'>increased126 bps</font>&nbsp;to3.3%; LTL&nbsp;<font color='red'>declined 525 bps</font>&nbsp;to -6.9% &amp; Ascent&nbsp;<font color='green'>increased 132 bps</font>&nbsp;to 5.9%.</li><li>In Q1, the company announced the integration and rebranding of several operating companies, including Roadrunner Truckload Plus, into Ascent Global Logistics.</li><li>Also, the company restructured its temperature controlled truckload business which amounted to ~$5-7M in Q2 related to fleet and facilities right-sizing and severance costs.</li><li>The company issued and sold shares of Series E-1 Preferred Stock of ~$17.5M on March 1, 2018 and $17.5M on April 24, 2018.</li><li>The company has ~$40M of available funds for working capital and operating purposes from its existing borrowing capacity under its ABL facility and standby commitment from its preferred stock investor.</li><li>Positive 2018 Outlook: Expects improved operating and financial results throughout 2018 and a steady expansion of operating margins in future years.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367331-roadrunner-transportation-reports-q1-results\" target=\"_blank\">Roadrunner Transportation reports Q1 results</a> (July 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367467\" data-linked=\"Roadrunner Transportation Systems up 6.2% post Q1 results\" data-tweet=\"$RRTS - Roadrunner Transportation Systems up 6.2% post Q1 results https://seekingalpha.com/news/3367467-roadrunner-transportation-systems-up-6_2-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3367467-roadrunner-transportation-systems-up-6_2-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367465\" data-ts=\"1530540375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NANO\" target=\"_blank\">NANO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367465-nanometricsplus-1_7-on-target-raise-to-19-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nanometrics +1.7% on target raise to 19% upside</a></h4><ul><li>           DA Davidson <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Nanometrics+%28NANO%29+PT+Raised+to+%2442+at+DA+Davidson/14362757.html\" target=\"_blank\">maintains</a> a Buy rating on Nanometrics (NASDAQ:<a href='https://seekingalpha.com/symbol/NANO' title='Nanometrics Incorporated'>NANO</a>) and raises the price target from $35 to $42, a 19% upside to Friday&rsquo;s close.&nbsp; </li><li> Nanometrics shares are&nbsp;<font color='green'>up 1.7%</font>&nbsp;to $36.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3367465\" data-linked=\"Nanometrics +1.7% on target raise to 19% upside\" data-tweet=\"$NANO $ONTO - Nanometrics +1.7% on target raise to 19% upside https://seekingalpha.com/news/3367465-nanometricsplus-1_7-on-target-raise-to-19-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3367465-nanometricsplus-1_7-on-target-raise-to-19-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367464\" data-ts=\"1530540357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCAR\" target=\"_blank\">PCAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367464-paccarminus-3-after-wedbush-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PACCAR -3% after Wedbush downgrade</a></h4><ul> <li>PACCAR (NASDAQ:<a href='https://seekingalpha.com/symbol/PCAR' title='PACCAR Inc.'>PCAR</a>) is <font color='red'>down 2.66%</font> in early trading after Robert W. Baird lowers the vehicle maker to an Underperform rating after having the stock set at Neutral.</li> <li>Shares of PACCAR slipped below $60 for the first time in more than a year within the last half hour.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3367464\" data-linked=\"PACCAR -3% after Wedbush downgrade\" data-tweet=\"$PCAR - PACCAR -3% after Wedbush downgrade https://seekingalpha.com/news/3367464-paccarminus-3-after-wedbush-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3367464-paccarminus-3-after-wedbush-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367453\" data-ts=\"1530539395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFBC\" target=\"_blank\">PFBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367453-preferred-bank-gains-4_4-after-joining-s-and-p-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Preferred Bank gains 4.4% after joining S&amp;P SmallCap 600</a></h4><ul><li>Preferred Bank (NASDAQ:<a href='https://seekingalpha.com/symbol/PFBC' title='Preferred Bank'>PFBC</a>) gains&nbsp;<font color='green'>4.4%</font>&nbsp;in morning trading after S&amp;P Dow Jones Indices said on Friday it will <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/734552_preferredinsurance6.pdf?force_download=true\" target=\"_blank\">add the bank</a> to the S&amp;P SmallCap 600.</li><li>It replaces Infinity Property &amp; Casualty (NASDAQ:<a href='https://seekingalpha.com/symbol/IPCC' title='Infinity Property and Casualty Corporation'>IPCC</a>), which is being acquired by Kemper (NYSE:<a href='https://seekingalpha.com/symbol/KMPR' title='Kemper Corporation'>KMPR</a>); closing is expected today.</li><li>PFBC will be added to the index before trading opens on Friday, July 6.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367453\" data-linked=\"Preferred Bank gains 4.4% after joining S&amp;P SmallCap 600\" data-tweet=\"$PFBC $PFBC $IPCC - Preferred Bank gains 4.4% after joining S&amp;P SmallCap 600 https://seekingalpha.com/news/3367453-preferred-bank-gains-4_4-after-joining-s-and-p-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3367453-preferred-bank-gains-4_4-after-joining-s-and-p-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367448\" data-ts=\"1530538873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367448-nielsen-holdingsminus-2-goldman-cuts-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen Holdings -2% as Goldman cuts to Sell</a></h4><ul>   <li>Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a>) is <font color='red'>2% lower</font> after a downgrade to Sell at Goldman Sachs.</li>    <li>The firm lowered its price target to $28 from $35, implying 7.6% downside from the lower price today.</li>    <li>Shares are <font color='red'>down 15%</font> YTD though they're slightly above flat for the past quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367448\" data-linked=\"Nielsen Holdings -2% as Goldman cuts to Sell\" data-tweet=\"$NLSN - Nielsen Holdings -2% as Goldman cuts to Sell https://seekingalpha.com/news/3367448-nielsen-holdingsminus-2-goldman-cuts-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3367448-nielsen-holdingsminus-2-goldman-cuts-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367444\" data-ts=\"1530538653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLFS\" target=\"_blank\">BLFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367444-biolife-sees-103-increase-in-q2-revenue-guidance-raised-shares-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLife sees 103% increase in Q2 revenue; guidance raised; shares up 15%</a></h4><ul><li>Thinly traded micro cap BioLife Solutions (<a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+15.2%</font>) is up out the gate on the heels of its <a href=\"https://seekingalpha.com/pr/17206659-biolife-solutions-reports-second-quarter-2018-preliminary-revenue-5_2-million-103-percent\" target=\"_blank\">announcement </a>that Q2 revenues should be $5.2M, up 103% yoy and up 36% sequentially.</li><li>The company has boosted it 2018 biopreservation media revenue guidance to $18.5M - 20.0M from $14.5M - 15.5M. It previously announced guidance for gross margin, operating expenses, GAAP operating profit and non-GAAP EBITDA and cash flow ops remain as is.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367444\" data-linked=\"BioLife sees 103% increase in Q2 revenue; guidance raised; shares up 15%\" data-tweet=\"$BLFS - BioLife sees 103% increase in Q2 revenue; guidance raised; shares up 15% https://seekingalpha.com/news/3367444-biolife-sees-103-increase-in-q2-revenue-guidance-raised-shares-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3367444-biolife-sees-103-increase-in-q2-revenue-guidance-raised-shares-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367443\" data-ts=\"1530538589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTCKF\" target=\"_blank\">HTCKF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367443-htc-lays-off-1500-from-taiwan-division-doesnt-include-google-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HTC lays off 1,500 from Taiwan division, doesn&#39;t include Google group</a></h4><ul><li>        HTC (<a href='https://seekingalpha.com/symbol/HTCKF' title='HTC Corporation'>OTC:HTCKF</a>) will <a href=\"https://www.theverge.com/2018/7/2/17524936/htc-lay-off-1500-employees-taiwan-reorganize-profit\" target=\"_blank\">lay off</a> 1,500 employees from its Taiwan division to save money after a pattern of poor quarterly results.</li><li>               The employees don&rsquo;t belong to the group of 2K workers that went to Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='red'>-1.5%</font>) in the $1.1B purchase.&nbsp;</li><li>               The cut represents about 22% of total employees.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367417-susquehanna-upgrades-tsmc-31-percent-upside\" target=\"_blank\">Susquehanna upgrades TSMC to 31% upside</a> (July 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367443\" data-linked=\"HTC lays off 1,500 from Taiwan division, doesn&#39;t include Google group\" data-tweet=\"$HTCKF $HTCKF $GOOG - HTC lays off 1,500 from Taiwan division, doesn&#39;t include Google group https://seekingalpha.com/news/3367443-htc-lays-off-1500-from-taiwan-division-doesnt-include-google-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3367443-htc-lays-off-1500-from-taiwan-division-doesnt-include-google-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367437\" data-ts=\"1530537987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367437-tesla-updates-on-production-and-reservations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla updates on production and reservations</a></h4><ul> <li>Hang on tight because the Q2 delivery and production numbers are in from Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) this morning.</li><li>The company says Q2 production totaled 53,339 vehicles, up 55% Q/Q. Model 3 production came in at 28,578 units, while combined Model S and X production was 24,761 units.</li><li>During the last seven days of the quarter, production of 5,031 Model 3 and 1,913 Model S/X combines was realized.</li>  <li>\"GA4, our new General Assembly line for Model 3, was responsible for roughly 20% of Model 3s produced last week, with quality from that line being as good as our regular GA3 line. We expect that GA3 alone can reach a production rate of 5,000 Model 3s per week soon, but GA4 helped to get us there faster and will also help to exceed that rate,\" updates Tesla.</li>  <li>Tesla expects to increase production to 6K&nbsp;Model 3s per week by late next month. Management also reaffirms guidance for positive GAAP net income and cash flow in Q3 and Q4, despite negative pressures from a weaker U.S. dollar and&nbsp;likely higher tariffs for vehicles imported into China as well as components procured from China.</li>  <li>Q2 deliveries totaled 40,740 vehicles, of which 18,440 were Model 3, 10,930 were Model S, and 11,370 were Model X. Tesla notes that&nbsp;11,166 Model 3 vehicles and 3,892 Model S and X vehicles were in transit to customers at the end of Q2, and will be delivered in early Q3. The high number of customer vehicles in transit for Model 3 was primarily due to a significant increase in production towards the end of the quarter.</li><li>Interesting news on reservations is in from Tesla. \"The remaining net Model 3 reservations count at the end of Q2 still stood at roughly 420,000 even though we have now delivered 28,386 Model 3 vehicles to date,\" updates the EV automaker. There's been plenty of speculation on how patient Model 3 reservation holders would be through the slow Model production ramp.</li><li>TSLA  <font color='green'>+5.99%</font> premarket to  $363.52.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17206875-tesla-q2-2018-vehicle-production-deliveries\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3367437\" data-linked=\"Tesla updates on production and reservations\" data-tweet=\"$TSLA - Tesla updates on production and reservations https://seekingalpha.com/news/3367437-tesla-updates-on-production-and-reservations?source=tweet\" data-url=\"https://seekingalpha.com/news/3367437-tesla-updates-on-production-and-reservations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>487&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367434\" data-ts=\"1530537833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367434-fda-oks-teligents-lidocaine-and-prilocaine-cream-shares-up-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Teligent&#39;s lidocaine and prilocaine cream; shares up 6% premarket</a></h4><ul><li>Micro cap Teligent (NASDAQ:<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on light volume in response to the <a href=\"https://seekingalpha.com/pr/17206692-teligent-inc-announces-fda-approval-lidocaine-prilocaine-cream-usp-2_5-percent-2_5-percent\" target=\"_blank\">FDA approval</a>&nbsp;for&nbsp;its Lidocaine and Prilocaine Cream USP, 2.5%/2.5%, its seventh approval this year.</li><li>Per IQVIA, the U.S. market is ~$44M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367434\" data-linked=\"FDA OKs Teligent&#39;s lidocaine and prilocaine cream; shares up 6% premarket\" data-tweet=\"$TLGT - FDA OKs Teligent&#39;s lidocaine and prilocaine cream; shares up 6% premarket https://seekingalpha.com/news/3367434-fda-oks-teligents-lidocaine-and-prilocaine-cream-shares-up-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3367434-fda-oks-teligents-lidocaine-and-prilocaine-cream-shares-up-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367432\" data-ts=\"1530537757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367432-premarket-losers-of-9-05-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (07/02/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a>&nbsp;<font color='red'>-29%</font>&nbsp;on CEO Petit <a href=\"https://seekingalpha.com/news/3367395-ceo-petit-mimedx\" target=\"_blank\">out</a>.</li><li><a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>&nbsp;<font color='red'>-6%</font>&nbsp;on direct <a href=\"https://seekingalpha.com/pr/17206879-fibrocell-announces-4_0-million-registered-direct-offering-priced-market\" target=\"_blank\">offering</a>.</li><li><a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a>&nbsp;<font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a>&nbsp;<font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367432\" data-linked=\"Premarket Losers as of 9:05 am (07/02/2018)\" data-tweet=\"$MDXG $MDXG $FCSC - Premarket Losers as of 9:05 am (07/02/2018) https://seekingalpha.com/news/3367432-premarket-losers-of-9-05-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367432-premarket-losers-of-9-05-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367431\" data-ts=\"1530537548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMP\" target=\"_blank\">ADMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367431-premarket-gainers-of-9-05-07-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (07/02/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='green'>+61%</font>&nbsp;as Novartis <a href=\"https://seekingalpha.com/news/3367324-novartis-scoops-rights-epipen-rival\" target=\"_blank\">scoops up</a> rights to EpiPen rival.</li>     <li><a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+31%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='green'>+27%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a> <font color='green'>+17%</font>&nbsp;as Bayer on go with clinical <a href=\"https://seekingalpha.com/news/3367367-bayer-go-clinical-development-compugen-discovered-therapeutic-antibody\" target=\"_blank\">development</a> of Compugen-discovered therapeutic antibody.</li>     <li>DVMT <font color='green'>+12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3367371-dell-13_6-percent-tracking-stock-purchase\" target=\"_blank\">tracking</a> stock purchase.</li>     <li><a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3367426-fortress-bio-11-percent-premarket-accelerated-review-status-u-s-cutxminus-101\" target=\"_blank\">accelerated</a> review status in U.S. for CUTX-101.</li>     <li><a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a> <font color='green'>+8%</font>&nbsp;on special <a href=\"https://seekingalpha.com/pr/17206541-vmware-announces-one-time-special-dividend-stockholders\" target=\"_blank\">dividend</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+8%</font>&nbsp;as&nbsp;Q2 <a href=\"https://seekingalpha.com/news/3367388-transenterix-sees-q2-sales-high-6_3m-shares-ahead-11-percent-premarket\" target=\"_blank\">sales</a> as high as $6.3M.</li>     <li><a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc ADR'>MFGP</a> <font color='green'>+5%</font>&nbsp;on $2.5B SUSE business <a href=\"https://seekingalpha.com/news/3367361-micro-focus-plus-5_4-percent-2_5b-suse-business-sale\" target=\"_blank\">sale</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+5%</font>&nbsp;after Model 3 production <a href=\"https://seekingalpha.com/news/3367357-tesla-rallies-model-3-production-update\" target=\"_blank\">update</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367431\" data-linked=\"Premarket Gainers as of 9:05 am (07/02/2018)\" data-tweet=\"$ADMP $ADMP $GBR - Premarket Gainers as of 9:05 am (07/02/2018) https://seekingalpha.com/news/3367431-premarket-gainers-of-9-05-07-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3367431-premarket-gainers-of-9-05-07-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367429\" data-ts=\"1530537472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367429-redhill-nabs-new-patents-covering-rhbminus-104\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Redhill nabs new patents covering RHB-104</a></h4><ul><li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) <a href=\"https://seekingalpha.com/pr/17206593-redhill-biopharma-announces-allowance-two-new-rhbminus-104-patents-ahead-top-line-phase-iii\" target=\"_blank\">announces </a>that the USPTO and the European Patent Office have issued notices that they intend to issue two new patents covering Crohn's disease candidate RHB-104, currently in Phase 3 development.</li><li>The patents, once issued, will be in effect until 2029.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367429\" data-linked=\"Redhill nabs new patents covering RHB-104\" data-tweet=\"$RDHL - Redhill nabs new patents covering RHB-104 https://seekingalpha.com/news/3367429-redhill-nabs-new-patents-covering-rhbminus-104?source=tweet\" data-url=\"https://seekingalpha.com/news/3367429-redhill-nabs-new-patents-covering-rhbminus-104\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367426\" data-ts=\"1530536802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367426-fortress-bio-up-11-premarket-on-accelerated-review-status-in-u-s-for-cutxminus-101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortress Bio up 11% premarket on accelerated review status in U.S. for CUTX-101</a></h4><ul><li>Thinly traded micro cap Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>) is up&nbsp;<font color='green'>11%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17206770-fortress-biotech-announces-cyprium-therapeutics-cutxminus-101-copper-histidinate-granted-fda\" target=\"_blank\">announcement </a>that the FDA has granted Fast Track status for Phase 3-stage CUTX-101 (copper histidinate) for the treatment of classic <a href=\"https://emedicine.medscape.com/article/1180460-overview\" target=\"_blank\">Menkes disease</a>, a neurodegenerative disorder caused by impaired copper transport.</li><li>CUTX-101 also has Orphan Drug status for the indication.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367426\" data-linked=\"Fortress Bio up 11% premarket on accelerated review status in U.S. for CUTX-101\" data-tweet=\"$FBIO - Fortress Bio up 11% premarket on accelerated review status in U.S. for CUTX-101 https://seekingalpha.com/news/3367426-fortress-bio-up-11-premarket-on-accelerated-review-status-in-u-s-for-cutxminus-101?source=tweet\" data-url=\"https://seekingalpha.com/news/3367426-fortress-bio-up-11-premarket-on-accelerated-review-status-in-u-s-for-cutxminus-101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367419\" data-ts=\"1530536472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367419-australia-forecasts-iron-ore-prices-falling-fifth-2020\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Australia forecasts iron ore prices falling more than a fifth by 2020</a></h4><ul>     <li>Australia sees iron ore prices <a href=\"https://www.reuters.com/article/australia-resources-iron-ore/australia-sees-iron-ore-prices-sliding-more-than-a-5th-by-2020-idUSL4N1TY2LZ\" target=\"_blank\">falling by more than 20%</a> over the next two years as demand from China&rsquo;s steel mills slips while domestic and Brazilian production increases, according to a new government report.</li>     <li>BHP&nbsp;Billiton (NYSE:<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a>) <font color='red'>-2%</font>, Rio Tinto (NYSE:<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a>) <font color='red'>-1.8%</font> and Vale (NYSE:<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>) <font color='red'>-1.7%</font> in premarket trading.</li>     <li>In its quarterly Resources and Energy report, Australia&rsquo;s Department of Industry forecasts FOB iron ore prices will fall to an average of $51/metric ton in 2020, more than 21% below the current $65/ton.</li>     <li>The report also says near iron ore prices should find some support as steel prices themselves head higher, with a positive outlook for industrial production and a seasonal rebound in construction activity in China&rsquo;s spring will shore up prices to average $59/ton FOB Australia this year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367419\" data-linked=\"Australia forecasts iron ore prices falling more than a fifth by 2020\" data-tweet=\"$BHP $BHP $RIO - Australia forecasts iron ore prices falling more than a fifth by 2020 https://seekingalpha.com/news/3367419-australia-forecasts-iron-ore-prices-falling-fifth-2020?source=tweet\" data-url=\"https://seekingalpha.com/news/3367419-australia-forecasts-iron-ore-prices-falling-fifth-2020\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367417\" data-ts=\"1530536347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367417-susquehanna-upgrades-tsmc-to-31-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna upgrades TSMC to 31% upside</a></h4><ul><li>        Susquehanna upgrades Taiwan Semiconductor Manufacturing Co. (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) from Neutral to Positive.</li><li>               Price target: $48, a 31% upside to Friday&rsquo;s close.&nbsp;</li><li>               Analyst Mehdi Hosseini sees TSMC as well positioned to benefit from AI investment strategies, 5Q network build-up, and cloud service growth.&nbsp;</li><li>               The analyst says TSMC has limited crypto exposure and notes that the recent 25% pullback has improved the risk-reward balance.&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               TSMC shares are&nbsp;<font color='red'>down 1.1%</font>&nbsp;premarket. Taiwan-based stocks are taking a hit after HTC <a href=\"https://www.taiwannews.com.tw/en/news/3472177\" target=\"_blank\">announced plans</a> to cut 1,500 jobs in the region.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3367417\" data-linked=\"Susquehanna upgrades TSMC to 31% upside\" data-tweet=\"$TSM - Susquehanna upgrades TSMC to 31% upside https://seekingalpha.com/news/3367417-susquehanna-upgrades-tsmc-to-31-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3367417-susquehanna-upgrades-tsmc-to-31-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367413\" data-ts=\"1530535896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNX\" target=\"_blank\">ATNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367413-athenex-up-17-premarket-on-100m-capital-raise-and-two-business-development-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athenex up 17% premarket on $100M capital raise and two business development deals</a></h4><ul><li>Thinly traded Athenex (NASDAQ:<a href='https://seekingalpha.com/symbol/ATNX' title='Athenex, Inc.'>ATNX</a>) is up&nbsp;<font color='green'>17%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17206556-athenex-announces-pipeline-expansion-initiatives-conjunction-strategic-investment-100-million\" target=\"_blank\">announcement </a>of three prospect-boosting deals.</li><li>A $100M investment from Perceptive Advisors, half in equity and half in debt.</li><li>A joint venture &#40;JV&#41;&nbsp;in China with Xiangxue Life Sciences called Axis Therapeutics Limited to research, development and commercialize T-cell receptor-engineered T cells for the treatment of cancer. Athenex will be the majority (55%) owner and will issue $5M of its common stock to Xiangxue and up to $110M in milestones. It will also contribute $30M to the JV.</li><li>In-licensing of global rights to a pegylated genetically modified human arginase from Avalon PolyTom Limited.&nbsp;Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367413\" data-linked=\"Athenex up 17% premarket on $100M capital raise and two business development deals\" data-tweet=\"$ATNX - Athenex up 17% premarket on $100M capital raise and two business development deals https://seekingalpha.com/news/3367413-athenex-up-17-premarket-on-100m-capital-raise-and-two-business-development-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3367413-athenex-up-17-premarket-on-100m-capital-raise-and-two-business-development-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367411\" data-ts=\"1530535881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SITC\" target=\"_blank\">SITC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367411-ddr-down-spinoff-retail-value-poised-to-start-regular-way-trading-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DDR down as spinoff Retail Value poised to start regular-way trading today</a></h4><ul><li>DDR Corp. (DDR)&nbsp;<font color='red'>loses 16%</font>&nbsp;in premarket on thin trading, reflecting the spinoff of Retail Value (NYSE:<a href='https://seekingalpha.com/symbol/RVI' title='Retail Value Inc'>RVI</a>), which starts regular-way trading today n the New York Stock Exchange under the ticker \"RVI\".</li><li>DDR shareholders received one RVI common share for every ten common shares of DDR held at the close of business on the record date of June 26, 2018.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17206648-ddr-announces-completion-spin-retail-value-inc\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3367411\" data-linked=\"DDR down as spinoff Retail Value poised to start regular-way trading today\" data-tweet=\"$SITC $SITC $RVI - DDR down as spinoff Retail Value poised to start regular-way trading today https://seekingalpha.com/news/3367411-ddr-down-spinoff-retail-value-poised-to-start-regular-way-trading-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3367411-ddr-down-spinoff-retail-value-poised-to-start-regular-way-trading-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367400\" data-ts=\"1530534800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNT\" target=\"_blank\">MLNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367400-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics'>MLNT</a>) initiated with Overweight rating and $15 (136%&nbsp; upside) price target at Cantor Fitzgerald.</li><li>ResMed (NYSE:<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a>) initiated with Buy rating at Goldman Sachs.</li><li>Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) initiated with Overweight rating and $19 (169% upside) price target at Cantor. Shares up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li><li>Dexcom (NASDAQ:<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a>) upgraded to Outperform with a $107 (13% upside) price target at Raymond James. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>Arsanis (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) downgraded to Market Perform at Cowen and Company. Shares up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li><li>Community Healthcare Trust (NYSE:<a href='https://seekingalpha.com/symbol/CHCT' title='Community Healthcare Trust'>CHCT</a>) downgraded to Neutral at Evercore ISI.</li><li>Integra LIfeSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/IART' title='Integra LifeSciences Holdings Corporation'>IART</a>) downgraded to Neutral at Citigroup.</li><li>Nevro (NYSE:<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a>) downgraded to Equal Weight at Mizuho.</li><li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) downgraded to Neutral at Mizuho. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367400\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$MLNT $MLNT $RMD - Premarket analyst action - healthcare https://seekingalpha.com/news/3367400-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3367400-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367395\" data-ts=\"1530533870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367395-ceo-petit-out-mimedx\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CEO Petit out at MiMedx</a></h4><ul><li>The internal investigation by MiMedx's (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a>) Audit Committee has forced the <a href=\"https://www.sec.gov/Archives/edgar/data/1376339/000119312518210478/d655278dex991.htm\" target=\"_blank\">resignations </a>of Chairman &amp; CEO Pete Petit and President &amp; COO Bill Taylor effective June 30, although Petit will continue to serve as a board member.</li><li>Board members Charles Evans and David Coles have been appointed Chairman and interim CEO, respectively. Mr. Coles is Managing Director at turnaround consultancy Alvarez &amp; Marsal.</li><li>Shares, currently halted, will resume trading at 8:30 am ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362290-mimedx-restate-six-years-financial-statements-withdraws-2018-guidance\" target=\"_blank\">MiMedx to restate six years of financial statements, withdraws 2018 guidance</a> (June 7)</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>31%</font>&nbsp;premarket on resumption of trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367395\" data-linked=\"CEO Petit out at MiMedx\" data-tweet=\"$MDXG - CEO Petit out at MiMedx https://seekingalpha.com/news/3367395-ceo-petit-out-mimedx?source=tweet\" data-url=\"https://seekingalpha.com/news/3367395-ceo-petit-out-mimedx\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>209&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367394\" data-ts=\"1530533842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKEP\" target=\"_blank\">BKEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367394-blueknight-energy-to-sell-three-asphalt-terminals-for-90m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blueknight Energy to sell three asphalt terminals for $90M</a></h4><ul>     <li>Blueknight Energy Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/BKEP' title='Blueknight Energy Partners'>BKEP</a>)&nbsp;<font color='green'>+5.9%</font> premarket after <a href=\"https://seekingalpha.com/pr/17206317-blueknight-announces-sale-three-asphalt-terminals-ergon-amends-credit-facility-completes\" target=\"_blank\">agreeing to sell</a> three asphalt terminals in Texas and Tennessee to Ergon for $90M.</li>     <li>Ergom indirectly owns 100% of Blueknight Energy Partners GP, the general partner of BKEP and 27.5% of the limited partnership interests in BKEP.</li>     <li>BKEP says it also amended its credit facility to allow for an investment of as much as $55M in the previously announced Cimarron Express joint venture, reduce commitments under the credit facility to $400M from $450M, limit distributions to $10.7M per quarter until year-end 2019, and provide financial covenant relief.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367394\" data-linked=\"Blueknight Energy to sell three asphalt terminals for $90M\" data-tweet=\"$BKEP - Blueknight Energy to sell three asphalt terminals for $90M https://seekingalpha.com/news/3367394-blueknight-energy-to-sell-three-asphalt-terminals-for-90m?source=tweet\" data-url=\"https://seekingalpha.com/news/3367394-blueknight-energy-to-sell-three-asphalt-terminals-for-90m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367392\" data-ts=\"1530533722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMNY\" target=\"_blank\">HMNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367392-helios-and-matheson-files-to-sell-securities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helios and Matheson files to sell more securities</a></h4><ul> <li>Helios and Matheson Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>) discloses a $1.2B mixed shelf securities filing with the SEC.</li><li>A filing by the company has been largely expected by investors.</li> <li>HMNY <font color='red'>-12.94%</font> premarket to $0.2699.</li> <li><a href=\"https://seekingalpha.com/filing/4086253\" target=\"_blank\">SEC Form S-3</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3367392\" data-linked=\"Helios and Matheson files to sell more securities\" data-tweet=\"$HMNY - Helios and Matheson files to sell more securities https://seekingalpha.com/news/3367392-helios-and-matheson-files-to-sell-securities?source=tweet\" data-url=\"https://seekingalpha.com/news/3367392-helios-and-matheson-files-to-sell-securities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367388\" data-ts=\"1530533046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRXC\" target=\"_blank\">TRXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367388-transenterix-sees-q2-sales-high-6_3m-shares-ahead-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransEnterix sees Q2 sales as high as $6.3M; shares ahead 11% premarket</a></h4><ul><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) is up&nbsp;<font color='green'>11%&nbsp;</font>premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17206574-transenterix-provides-corporate-update\" target=\"_blank\">announcement </a>of preliminary Q2 results.</li><li>It expects revenues of $6.0M - 6.3M.</li><li>Four Senhance Systems sold.</li><li>Quick assets totaled ~$98M at the end of June.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367388\" data-linked=\"TransEnterix sees Q2 sales as high as $6.3M; shares ahead 11% premarket\" data-tweet=\"$TRXC - TransEnterix sees Q2 sales as high as $6.3M; shares ahead 11% premarket https://seekingalpha.com/news/3367388-transenterix-sees-q2-sales-high-6_3m-shares-ahead-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3367388-transenterix-sees-q2-sales-high-6_3m-shares-ahead-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367387\" data-ts=\"1530532992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367387-macau-sector-slides-after-june-ggr-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau sector slides after June GGR disappoints</a></h4><ul> <li>The Macau sector sold off in Hong Kong this morning, while in the U.S. premarket session Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) is <font color='red'>down 3.79%</font> and Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) is <font color='red'>off 3.29%</font>.</li> <li>Union Gaming analyst Grant Govertsen notes that Macau casino business volume decelerated sharply in the last week of June. \"We're surveying the market to see if there was a universal root cause, but at this point we're not concerned. Keep in mind that Macau has bad weeks all the time and one bad week doesn't make a trend,\" notes Govertsen.</li> <li>He also points out the sector ran into a tough comparable from a year ago when June GGR was up 26%, but only attributes a small fraction of the revenue miss to World Cup fascination.</li> <li>Macau casino stocks: Wynn Macau (<a href='https://seekingalpha.com/symbol/WYNMF' title='Wynn Macau Ltd.'>OTCPK:WYNMF</a>, <a href='https://seekingalpha.com/symbol/WYNMY' title='Wynn Macau Ltd. ADR'>OTCPK:WYNMY</a>), Sands China (<a href='https://seekingalpha.com/symbol/SCHYY' title='Sands China Ltd ADR'>OTCPK:SCHYY</a>, <a href='https://seekingalpha.com/symbol/SCHYF' title='Sands China Ltd'>OTCPK:SCHYF</a>), MGM China (<a href='https://seekingalpha.com/symbol/MCHVF' title='MGM China Holdings, Ltd.'>OTCPK:MCHVF</a>, <a href='https://seekingalpha.com/symbol/MCHVY' title='MGM China Holdings, Ltd. ADR'>OTCPK:MCHVY</a>, <a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>), Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>), SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>, <a href='https://seekingalpha.com/symbol/SJMHY' title='SJM Holdings Ltd. ADR'>OTCPK:SJMHY</a>), Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>).</li>     <li>Related ETF: <a href='https://seekingalpha.com/symbol/BJK' title='VanEck Vectors Gaming ETF'>BJK</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3367387\" data-linked=\"Macau sector slides after June GGR disappoints\" data-tweet=\"$WYNN $WYNN $LVS - Macau sector slides after June GGR disappoints https://seekingalpha.com/news/3367387-macau-sector-slides-after-june-ggr-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3367387-macau-sector-slides-after-june-ggr-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367384\" data-ts=\"1530532687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVTR\" target=\"_blank\">NVTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367384-nuvectra-not-quite-marketing-applications-for-virtus-device-shares-down-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuvectra not quite there with marketing applications for Virtus device; shares down 3% premarket</a></h4><ul><li>Thinly traded micro cap Nuvectra (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) slips&nbsp;<font color='red'>3%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17206634-nuvectra-provides-update-fda-tuv-sud-review-virtis-pma-ce-mark-applications\" target=\"_blank\">announcement </a>that its U.S. marketing application and its CE Mark application related to its Virtus neurostimulation device for the treatment of chronic urinary retention and symptoms of overactive bladder both face longer approval timelines.</li><li>The FDA has requested additional information related to any modifications or changes to the device, labeling and manufacturing and clarifications of MRI data. The company intends to submit its responses as soon as possible, after which the agency has up to 180 days to review the new information.</li><li>Its CE Mark application, through Munich, Germany-based T&Uuml;V S&Uuml;D, will require a clinical trial to support the filing. The breadth of required data is still being discussed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367384\" data-linked=\"Nuvectra not quite there with marketing applications for Virtus device; shares down 3% premarket\" data-tweet=\"$NVTR - Nuvectra not quite there with marketing applications for Virtus device; shares down 3% premarket https://seekingalpha.com/news/3367384-nuvectra-not-quite-marketing-applications-for-virtus-device-shares-down-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3367384-nuvectra-not-quite-marketing-applications-for-virtus-device-shares-down-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367371\" data-ts=\"1530531308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELL\" target=\"_blank\">DELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367371-dell-up-13_6-on-tracking-stock-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dell up 13.6% on tracking stock purchase</a></h4><ul><li>Dell Technologies (DVMT) <a href=\"https://seekingalpha.com/pr/17206540-special-committee-representing-dell-technologies-holders-class-v-common-stock-approves\" target=\"_blank\">confirm</a>s reports that it will buy out VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) tracking shares in a cash and equity deal.</li><li>Dell proposes an exchange of 1.3665 shares of Class C stock or $109 in cash for each share of tracking stock. The total cash consideration won&rsquo;t be above $9B.</li><li>The cash component will come from a one-time $11B special dividend VMware will pay to its shareholders. After the deal, VMware shareholders will own 20.8% to 31% of Dell depending on how many opt for cash.</li><li>The transaction represents a 29% premium on Dell&rsquo;s closing price on Friday.</li><li>Dell has discussed its strategic options for months due to a massive debt balance.</li><li>Dell shares are&nbsp;<font color='green'>up 13.6%</font>&nbsp;premarket.</li><li>VMware shares are&nbsp;<font color='green'>up 12.3%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367316-dell-go-public\" target=\"_blank\">Dell about to go public again?</a> (July 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358008-dell-talking-shareholders-full-vmware-merger-dvmt-plus-5_8-percent\" target=\"_blank\">Dell talking to shareholders about full VMware merger; DVMT +5.8%</a> (May 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3367371\" data-linked=\"Dell up 13.6% on tracking stock purchase\" data-tweet=\"$DELL $DELL $VMW - Dell up 13.6% on tracking stock purchase https://seekingalpha.com/news/3367371-dell-up-13_6-on-tracking-stock-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3367371-dell-up-13_6-on-tracking-stock-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367369\" data-ts=\"1530531082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367369-cowen-warns-on-nordstrom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen warns on Nordstrom</a></h4><ul> <li>Shares of Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) are on watch after Cowen downgrades the department store operator to Market Perform from Outperform.</li> <li>Cowen points to ongoing pressure at full-line stores and Rack outlets. THe analyst team notes that Nordstron's analyst day event on July 10 is a key event next week.</li> <li>JWN <font color='red'>-1.0%</font> premarket to $51.28 on light volume.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3367369\" data-linked=\"Cowen warns on Nordstrom\" data-tweet=\"$JWN - Cowen warns on Nordstrom https://seekingalpha.com/news/3367369-cowen-warns-on-nordstrom?source=tweet\" data-url=\"https://seekingalpha.com/news/3367369-cowen-warns-on-nordstrom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367362\" data-ts=\"1530530282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAYRY\" target=\"_blank\">BAYRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367362-compugen-up-10-fda-pulls-clinical-hold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compugen up 10% as FDA pulls clinical hold</a></h4><ul><li>The FDA has cleared Bayer AG's (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a>) investigational new drug application for BAY 1905254, a first-in-class immuno-oncology therapeutic antibody targeting the ILDR2 protein in patients with advanced solid tumors, says Compugen (NASDAQ:<a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a>).</li><li>Compugen is entitled to receive a milestone payment upon the first patient dosing with BAY 1905254 in the Phase 1 clinical trial expected in 2018.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17206613-b-compugen-b-welcomes-fda-clearance-bayers-ind-application-bay-1905254\" target=\"_blank\">Press Release</a></li><li>Shares&nbsp;<font color='green'>+10.6%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3367362\" data-linked=\"Compugen up 10% as FDA pulls clinical hold\" data-tweet=\"$BAYRY $BAYRY $CGEN - Compugen up 10% as FDA pulls clinical hold https://seekingalpha.com/news/3367362-compugen-up-10-fda-pulls-clinical-hold?source=tweet\" data-url=\"https://seekingalpha.com/news/3367362-compugen-up-10-fda-pulls-clinical-hold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367361\" data-ts=\"1530530091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFGP\" target=\"_blank\">MFGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367361-micro-focusplus-5_4-on-2_5b-suse-business-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micro Focus +5.4% on $2.5B SUSE business sale</a></h4><ul><li>        Micro Focus (NYSE:<a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc ADR'>MFGP</a>) <a href=\"https://seekingalpha.com/filing/4086184\" target=\"_blank\">will sell</a> its open source software SUSE business to Blitz 18-679 GmbH for $2.535B in cash.</li><li>               Micro Focus says the sale price represents an enterprise valuation at approximately 7.9x SUSE&rsquo;s revenue and 26.7x adjusted operating profit. &nbsp;&nbsp;</li><li>               The transaction is expected to complete in 1Q19.&nbsp;</li><li>               Micro Focus shares are&nbsp;<font color='green'>up 5.4%</font>&nbsp;premarket to $18.20.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3367361\" data-linked=\"Micro Focus +5.4% on $2.5B SUSE business sale\" data-tweet=\"$MFGP - Micro Focus +5.4% on $2.5B SUSE business sale https://seekingalpha.com/news/3367361-micro-focusplus-5_4-on-2_5b-suse-business-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3367361-micro-focusplus-5_4-on-2_5b-suse-business-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3367346\" data-ts=\"1530528783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3367346-astrazenecas-lynparza-okd-in-japan-for-type-of-breast-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca&#39;s Lynparza OK&#39;d in Japan for type of breast cancer</a></h4><ul><li>AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>) and collaboration partner Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) <a href=\"https://seekingalpha.com/pr/17206462-lynparza-olaparib-approved-japan-brca-mutated-metastatic-breast-cancer\" target=\"_blank\">announce </a>that LYNPARZA (olaparib) has been approved in Japan for the treatment of patients with unresectable or recurrent BRCA-mutated human epidermal growth factor receptor 2 (HER2)-negative breast cancer who have received prior chemotherapy.</li><li>The data supporting the approval was generated in the Phase 3 OlympiAD study that showed Lynparza extended progression-free survival &#40;PFS&#41; versus chemo (median of 7.0 months vs. 4.2 months).</li><li>LYNPARZA was first approved in Japan for maintenance treatment of platinum-resistant relapsed ovarian cancer.</li><li>AZN is down&nbsp;<font color='red'>1%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3367346\" data-linked=\"AstraZeneca&#39;s Lynparza OK&#39;d in Japan for type of breast cancer\" data-tweet=\"$AZN $AZN $MRK - AstraZeneca&#39;s Lynparza OK&#39;d in Japan for type of breast cancer https://seekingalpha.com/news/3367346-astrazenecas-lynparza-okd-in-japan-for-type-of-breast-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3367346-astrazenecas-lynparza-okd-in-japan-for-type-of-breast-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}